Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

被引：0
|
作者：
Xiao-hui Li
Chong-yu Zhao
En-liang Zhou
Xiao-jun Lin
机构：
[1] Collaborative Innovation Center for Cancer Medicine,Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China
[2] Sun Yat-sen University Cancer Center,undefined
来源：
BMC Cancer | / 22卷
关键词：
Adjuvant chemotherapy; Adverse reactions; Efficacy; Intrahepatic cholangiocarcinoma; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
    Kim, Young Saing
    Oh, Sung Yong
    Go, Se-Il
    Kang, Jung-Hun
    Park, Inkeun
    Song, Haa-Na
    Ji, Jun Ho
    Hwang, In Gyu
    Jang, Joung-Soon
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 99 - 106
  • [32] Adjuvant chemotherapy for ypT0N0M0 rectal cancer following chemoradiotherapy and total mesorectal excision
    Kainthla, Radhika
    Huerta, Sergio
    ANTI-CANCER DRUGS, 2016, 27 (09) : 819 - 823
  • [33] A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy
    Xu, Quan
    Kang, Wen-Zhe
    Xiong, Jian-Ping
    Shao, Xin-Xin
    Li, Wei-Kun
    Hu, Hai-Tao
    Tian, Yan-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (38) : 5626 - 5635
  • [34] Adjuvant Chemotherapy with Uracil-Tegafur for Pathological T1aN0M0 Lung Adenocarcinoma with Lymphatic Vessel Invasion
    Kitamura, Y.
    Nishio, W.
    Tanaka, H.
    Minami, K.
    Okuma, H.
    Yoshimura, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1963 - S1963
  • [35] Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis
    Chen, YiPing
    Weng, ShanGeng
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (08) : 1989 - 1999
  • [36] Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms
    Ohmori, Yukimi
    Nomura, Takashi
    Fukushima, Norimasa
    Takahashi, Fumiaki
    Iwaya, Takeshi
    Koeda, Keisuke
    Nishizuka, Satoshi S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1154 - 1161
  • [37] Adjuvant Chemotherapy in cT1N0M0 Large-Cell Neuroendocrine Cancer with or without Pathological Upstaging
    Suzuki, Y.
    Sarkaria, I. S.
    Christie, I. G.
    Mazur, S. N.
    Kim, S.
    Pennathur, A.
    Luketich, J. D.
    Landreneau, R.
    Schuchert, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S365 - S365
  • [38] Ovarian conservation is associated with better survival in young patients with T1N0M0 cervical adenocarcinoma: a population-based study
    Xu, He-Yang
    Tang, Xiaoyan
    Ding, Jingxin
    Qiu, Junjun
    Zhang, Xuyin
    Hua, Keqin
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (03) : 775 - 784
  • [39] Ovarian conservation is associated with better survival in young patients with T1N0M0 cervical adenocarcinoma: a population-based study
    He-Yang Xu
    Xiaoyan Tang
    Jingxin Ding
    Junjun Qiu
    Xuyin Zhang
    Keqin Hua
    Archives of Gynecology and Obstetrics, 2018, 297 : 775 - 784
  • [40] Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis
    YiPing Chen
    ShanGeng Weng
    Journal of Gastrointestinal Surgery, 2021, 25 : 1989 - 1999
12345